Insulin and IGF1 modulate neuronal growth, survival, metabolism, synapse formation, and plasticity, and insulin, IGF1 polypeptides, and their receptors are expressed in the brain, most abundantly in regions that are most vulnerable to AD neurodegeneration (de la Monte & Wands, 2005). This evidence concerns the gene INS and Alzheimer disease.